Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharma Readies For Bioterrorism: BIO Survey Says Security Systems Adequate

Executive Summary

A Biotechnology Industry Organization survey of approximately 1,000 member companies indicates that the biotech industry's security systems are adequate in the case of a bioterrorist attack.

You may also be interested in...



Kennedy/Frist: $100 Mil. For FDA Bioterrorism Product Review, Food Safety

Sens. Bill Frist (R-Tenn.) and Edward Kennedy (D-Mass.) are requesting $100 mil. to improve FDA review of products and food safety related to bioterrorism.

CDER Antibioterrorism Efforts Focus On Small Pox And Plague

The Center for Drug Evaluation & Research's antibioterrorism efforts are focusing on development of drugs to counter small pox and plague.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038639

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel